Company Number: 15018004

Analysis Date: 2025-07-29 12:41 UTC

Financial Health Assessment for VENA MEDICALS LIMITED

---

1. Financial Health Score: D

Explanation:
Given the very early stage of the company (incorporated July 2023) and the financial data for the first accounting period ending July 2024, the company shows signs of financial distress. The net current assets and net assets are negative (£-231), indicating liabilities exceed assets, which is a symptom of financial strain. However, as a micro-entity with no employees and minimal recorded transactions, this may reflect startup phase investment or initial setup costs rather than operational failure. The score D reflects caution but acknowledges early-stage status.

---

2. Key Vital Signs

• Current Assets: £220
  Interpretation: Very low current assets, primarily cash or receivables. Indicates limited liquid resources at year-end.

• Current Liabilities: £451
  Interpretation: Short-term obligations exceed current assets by £231, revealing a working capital deficit. This is a key symptom of cash flow pressure.

• Net Current Assets (Working Capital): -£231
  Interpretation: Negative working capital is a warning sign that the company might face difficulty meeting short-term obligations without additional financing.

• Net Assets (Shareholders’ Funds): -£231
  Interpretation: The company’s total liabilities exceed its assets, meaning the equity base is negative. This is a critical red flag indicating financial stress.

• Employees: 0
  Interpretation: No staff employed during the period, typical for a very new or dormant startup phase.

• Company Age: ~1 year
  Interpretation: Early incorporation phase; many companies may run at a loss or negative equity initially.

---

3. Diagnosis

The financial "vital signs" suggest that VENA MEDICALS LIMITED is currently in a fragile financial state. The negative net assets and working capital deficits are symptoms akin to a patient showing signs of early distress—likely reflecting startup costs, investments in non-current assets or initial liabilities that have not yet been offset by operational revenue.

Given the company’s micro-entity status and infancy, these symptoms are not uncommon but warrant close monitoring. The absence of employees and minimal asset base indicate the company might still be in the setup or pre-revenue phase.

The governance structure appears sound, with two directors holding equal control and no indication of compliance or filing issues. The company is active, not in liquidation or administration.

---

4. Recommendations

• Improve Liquidity:
  Seek additional capital injections or short-term financing to cover immediate liabilities and improve working capital. Healthy cash flow is critical to avoid insolvency risks.

• Revenue Generation:
  Develop and execute a clear business plan focused on generating revenue streams to reverse negative equity and cover costs sustainably.

• Cost Control:
  Monitor and limit expenditures strictly until revenue stabilizes. Avoid unnecessary expenses that exacerbate negative working capital.

• Regular Financial Monitoring:
  Implement monthly cash flow forecasting and financial reporting to detect early warning signs of distress and take corrective action promptly.

• Stakeholder Communication:
  Maintain transparent communication with shareholders and creditors about financial status and plans to improve health, building trust and support.

• Consider Professional Advice:
  Engage financial advisors or accountants experienced with startups and healthcare sector to optimize financial structure and compliance.

---